Federal contract award
W911NF23C0062
STTR PHASE II: IMPROVED TECHNOLOGY TO TREAT DRUG-RESISTANT BACTERIAL INFECTIONS
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | W6QK ACC-APG DURHAM |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AJ11 — GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | SMALL BUSINESS SET ASIDE - TOTAL |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $1.2M |
| Current contract value | $1.2M |
| Potential contract value / ceiling | $1.2M |
| Start date | Sep 15, 2023 |
| Current end date | Sep 14, 2025 |
| Potential end date | Sep 14, 2025 |
| Latest award activity | May 29, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| May 29, 2025 | P00004 | $0 | IMPROVED TECHNOLOGY TO TREAT DRUG-RESISTANT BACTERIAL INFECTIONS |
| Jan 24, 2025 | P00003 | $0 | IMPROVED TECHNOLOGY TO TREAT DRUG-RESISTANT BACTERIAL INFECTIONS |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.